(3), 695. https://www.mdpi.com/2227-9059/13/3/695

Chen, H., et al. (2023). Pleiotrophin drives a prometastatic immune niche in breast cancer. Journal of Experimental Medicine, 220(5), e20220610. https://rupress.org/jem/article-abstract/220/5/e20220610/213899

Wang, J., et al. (2024). Pleiotrophin promote glioma proliferation and invasion by regulating epithelial-mesenchymal transition through the NF-κB pathway. European Journal of Medical Research, 29(1), 208. https://eurjmedres.biomedcentral.com/articles/10.1186/s40001-025-02808-9

Jain, S., et al. (2017). Therapeutic silence of pleiotrophin by targeted delivery of siRNA in a human prostate cancer model. PLOS ONE, 12(5), e0177964. https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0177964

Akyel, A., et al. (2022). Association of serum pleiotrophin levels with acute coronary syndrome. International Journal of Cardiovascular Academy, 8(3), 67-71. https://ijcva.org/articles/association-of-serum-pleiotrophin-levels-with-acute-coronary-syndrome/ijca.ijca_11_22

R&D Systems. (n.d.). Recombinant Human Pleiotrophin/PTN Protein, CF (252-PL). Bio-Techne. Retrieved from https://www.bio-techne.com/p/proteins-enzymes/recombinant-human-pleiotrophin-ptn-protein-cf_252-pl